Exact Sciences Corporation is a molecular diagnostics company that develops tests for the prevention, early detection, and treatment guidance of cancer. Founded in 1995, the firm employs more than 6,500 people across sites in Marlborough, Massachusetts, and Madison, Wisconsin. Its best-known product is Cologuard, a non-invasive, at-home screening test that detects colorectal cancer and precancerous polyps.
The company operates at significant scale: in 2023 more than four million patients used its tests, and its products are available in over 120 countries. Core technical domains include molecular diagnostics, cancer screening, and non-invasive testing, spanning the healthcare, diagnostics, and oncology sectors.
Exact Sciences has been certified as a Great Place To Work for seven consecutive years. The company states that it believes changing lives starts with supporting its team.
